Bio-IT World Magazine Announces Best of Show Awards Finalists


Cambridge Healthtech Institute’s Bio-IT World, the industry’s premier B-to-B publication addressing the technologies driving discovery, development and clinical trials, today announced the finalists of its Life Sciences Conference + Expo Best of Show Awards.  The winners will be announced at an awards ceremony on April 4 at the show, which takes place at the Sheraton Boston Hotel, April 3 – 5, 2006.

Judged by a team of Bio-IT World magazine editors and leading industry experts, the awards program spotlights new products that demonstrate exceptional technology innovation across the life sciences research, discovery, and clinical trials process. Finalists were chosen among entries submitted from leading bio-IT vendors exhibiting at the conference and expo, based on the products’ technical merit, functionality and innovation. Products considered as finalists are new products or significant product upgrades introduced between May 2005 and April 2006.

The judges selected the following products as Best of Show finalists within four core categories: 

Clinical Trials & Research

  • eClinical from DATATRAK International, Inc.
  • Rave 5.5 from Medidata Solutions
  • NetRM from Netregulus, Inc.
  • Clinical Trials Signal Detection System from Phase Forward, Inc.

Information Technology Infrastructure 

  • Isilon IQ Series from Isilon Systems, Inc.
  • Pipeline Pilot Platform 5.1 from Scitegic
  • Continuous Protection Systems 1200 from Revivio, Inc.

Knowledge Management & Collaboration 

  • MedScan from Ariadne Genomics, Inc.
  • Vivisimo Velocity for Life Sciences 4.2 from Vivisimo, Inc.
  • eLab Notebook 3.0 from Waters Corporation

Informatics Tools & Data

  • Expressionist version Pro 3.0 from Genedata
  • I2E 2.8 from Linguamatics
  • Discovery Solution 3.0 from Nervana, Inc.
  • XDA 2.8 from Teranode Corporation

 “Selected by prominent judges with years of experience in the bio-science fields, the Life Sciences Conference + Expo’s Best of Show Awards finalists consist of products within IT, informatics and life science technologies that have captured the attention of our judges because of their innovation and leadership in their respective markets,” said John Russell, executive editor, Bio-IT World . “These awards recognize the products that are fueling tomorrow’s discoveries.”

One winner in each category will be selected after judges have reviewed the products on the show floor at the Life Sciences Conference + Expo.  Executive Editor of Bio-IT World John Russell will present the awards at the ceremony April 4, from 6pm – 7pm. The awards ceremony, which will be held on the Expo floor, is open to all attendees, exhibitors and members of the press.  Winners of the Best of Show Awards will receive honorary signage, an awards logo, and an engraved award.  They also will be featured on the Bio-IT World website with additional coverage in an upcoming issue of the magazine. For complete coverage of the awards, along with continuous updates from Boston’s Life Sciences Conference + Expo by Bio-IT World editors, visit www.bio-itworld.com.

About Bio-IT World, Inc.
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT professionals.  Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance.

The company’s premier publication, Bio-IT World and accompanying website, www.bio-itworld.com, deliver the latest news, analysis and information on the indispensable technologies driving innovation in the bio-IT community. Bio-IT World also produces the Life Sciences Conference + Expo, now in it’s fifth year, along with supporting multiple industry events as strategic and business partners. Bio-IT World has received more than 34 awards for editorial and design excellence. Established in September 2001, Bio-IT World, Inc., headquartered in Framingham, MA., is a business of Cambridge Healthtech Institute.

About Cambridge Healthtech Institute
CHI’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk,  World Pharmaceutical Congress and the new acquired Bio-IT World’s Life Sciences Conference & Expo.  The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. Leading researchers and business experts from top pharmaceutical, biotech and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 400 conferences, attracting more than 50,000 attendees from around the world.

In addition to CHI’s vast conference portfolio, their media properties include PharmaWeek, available on the web only, Pharmaceutical Discovery which will relaunch in print and online in May following its acquisition last year from Advanstar Communications and Bio-IT World acquired in March 06.

# # #

For more information, contact:
Gina Bajenaru, Director of Marketing Communications
Bio-IT World, Inc.
Ph: (508) 628-4821
Gina_Bajenaru@bio-itworld.com                  

Press Contact:
Lisa Scimemi
Cambridge Healthtech Institute
Ph. (617) 630-1319
lscimemi@healthtech.com

                       

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.